Two-step liver transplant surgery for liver cancer
Part of Cancer, Digestive system clinical trials.
This trial studies a two-step liver transplant operation for people with hepatocellular carcinoma (a type of liver cancer) to improve outcomes compared with standard approaches. You may be screened with scans and blood tests to confirm your cancer is limited to the liver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 68 years old
- Your liver cancer plan for transplant was approved at a team meeting
- Your AFP blood test is low (≤ 2)
- Your body mass index (BMI) is under 30
- Your MELD score is 15 or lower and you don’t have priority access
- Your scans (PET-CT) show the cancer is only in the liver, not outside it
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving atezolizumab plus bevacizumab before liver transplant in people with hepatocellular carcinoma (HCC) that is too advanced to be listed within the “Milan criteria,” but still transplant-eligible. The goal is to control the cancer outside the transplant period and improve transplant outcomes.
This trial tests a combination of focused radiation (SBRT), an immunotherapy drug (adelimumab), and a targeted therapy pill (apatinib) before surgery for liver cancer. The goal is to shrink tumors enough to make surgery possible or more effective.
This trial tests a combination of two drugs (atezolizumab and bevacizumab) plus a targeted radiation treatment (Y-90 radioembolization) for people with liver cancer who are waiting for a liver transplant. The goal is to see if this treatment can help control the cancer and improve transplant outcomes.
This trial studies a treatment approach (a combination given through the liver) for people with early liver cancer that can be surgically removed but has a high chance of coming back. It may help reduce the risk of recurrence after treatment.
This trial looks at a special two-step surgery called ALPPS for people with liver cancer that can't be removed in one operation. The first step helps the liver grow more healthy tissue, and then the second step removes the tumor. The goal is to understand how well this works and how the liver regenerates.
This trial tests a two-step liver surgery approach for people with advanced (not fully removable) liver cancer or end-stage liver disease, using chemotherapy first when applicable. The goal is to see if this staged plan can better control disease and allow safer surgery.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.